Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-21
1994-01-11
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546281, 546282, C07D40104, A61K 3144
Patent
active
052781763
ABSTRACT:
Selective and potent nicotinic agonists of the formula: ##STR1## including pharmaceutically-acceptable salts or prodrugs thereof, useful in the treatment of dementias, attentional hyperactivity disorder, anxiety associated with cognitive impairment, or substance abuse withdrawal characterized by decreased cholinergic function.
REFERENCES:
patent: 4332945 (1982-06-01), Edwards
Murphy J. Biol. Chem. 1973, 248, 2796-800.
Clark et al. Principles of Psychopharmacology 1970 p. 166.
Rueppel et al. J.A.C.S. 1971, 93, 7021-8.
Merck Index Eleventh edition pp. 1281-1283.
Acheson et al. J. Chem. Soc. Perkin. Trans. 1980, 1: 579-85.
Wade J. R. Organic Chemistry p. 349, 1987.
Abbott Laboratories
Elder Richard A.
Fan Jane T.
Gorman, Jr. Edward H.
Weinstock Steven F.
LandOfFree
Nicotine derivatives that enhance cognitive function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotine derivatives that enhance cognitive function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotine derivatives that enhance cognitive function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631577